The mortality rate due to pancreas malignant neoplasms among women in Germany is predicted to steadily increase from 23.2 in 2024 to 23.5 deaths per hundred thousand women by 2028. Compared to 2023's baseline, a consistent yet modest year-on-year increase of approximately 0.4% is observed annually over the forecast period. This reflects a cumulative increase, indicating a gradual upward trend over five years.
Future trends to watch for include advancements in early detection and treatment options, which could alter mortality projections. Additionally, public health initiatives focusing on risk factor modification may play a role in potentially stabilizing or reducing future mortality rates.
